In today’s recent session, 1.51 million shares of the Indaptus Therapeutics Inc (NASDAQ:INDP) have been traded, and its beta is 1.72. Most recently the company’s share price was $0.75, and it changed around $0.09 or 14.07% from the last close, which brings the market valuation of the company to $10.87M. INDP at last check was trading at a discount to its 52-week high of $3.10, offering almost -313.33% off that amount. The share price’s 52-week low was $0.64, which indicates that the recent value has risen by an impressive 14.67% since then. We note from Indaptus Therapeutics Inc’s average daily trading volume that its 10-day average is 2.13 million shares, with the 3-month average coming to 380.24K.
Indaptus Therapeutics Inc stock received a consensus recommendation rating of Overweight, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended INDP as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Indaptus Therapeutics Inc (NASDAQ:INDP) trade information
Instantly INDP has been showing a green trend so far today with a performance of 14.07% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.8834 on recent trading dayincreased the stock’s daily price by 15.1%. The company’s shares are currently down -10.55% year-to-date, but still down -7.00% over the last five days. On the other hand, Indaptus Therapeutics Inc (NASDAQ:INDP) is -2.17% down in the 30-day period. We can see from the shorts that 58242.0 shares have been sold at a short interest cover period of 2.23 day(s).
Indaptus Therapeutics Inc (INDP) estimates and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 57.27%. Indaptus Therapeutics Inc earnings are expected to increase by 50.93% in 2025, but the outlook is positive 26.86% per year for the next five years.
Indaptus Therapeutics Inc (NASDAQ:INDP)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 42.01% of Indaptus Therapeutics Inc shares, and 14.20% of them are in the hands of institutional investors. The stock currently has a share float of 24.49%. Indaptus Therapeutics Inc stock is held by 21.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 3.0355% of the shares, which is about 0.26 million shares worth $0.54 million.
INVESTMENT HOUSE LLC, with 1.2134% or 0.1 million shares worth $0.22 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024. The former held 229.2 shares worth $0.17 million, making up 1.59% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 43.53 shares worth around $32207.0, which represents about 0.30% of the total shares outstanding.
